Section 2. CSB 4.02 (1) and (2) are amended to read:
CSB 4.02 (1) “Access” means to have the ability to view PDMP information through an account established with the board monitored prescription drug history reports, audit trails, and PDMP data as authorized by s. CSB 4.09. Section 3. CSB 4.02 (2m), (3s), (4m) and (5m) are created to read:
(3s) “Audit trail” means the log that contains information about each time the PDMP system discloses PDMP data, monitored prescription drug history reports, and prescribing metrics reports.
Section 4. CSB 4.02 (7) is amended to read:
Section 5. CSB 4.02 (11c) and (11n) are created to read:
CSB 4.02 (11c) “Healthcare Professional” means a pharmacist, practitioner, registered nurse licensed under s. 441.06, Stats., substance abuse counselor, as defined in s. 440.88 (1) (b), Stats. or individual authorized under s. 457.02 (5m), Stats. to treat alcohol or substance dependency or abuse as a specialty. (11n) “Law enforcement agency” has the meaning given in s. 165.77 (1) (b), Stats. Section 6. CSB 4.02 (11r) and (12) (a) 1. are amended to read:
CSB 4.02 (11r) “Managing pharmacist” has the meaning given in s. Phar 1.02 (6) means a pharmacist designated by the pharmacy owner to have responsibility for and direct control of pharmaceutical operations in a pharmacy. Section 7. CSB 4.02 (11w) and (12m) are created to read:
CSB 4.02 (11w) “Medical coordinator” means a person who medically coordinates, directs, supervises, or establishes standard operating procedures for a healthcare professional.
(12m) “Monitored prescription drug history report” means all of the following information about a patient, patient address, practitioner, or dispenser compiled by the PDMP system and disclosed as authorized in ss. CSB 4.09 and 4.11: (a) PDMP data.
(b) Reports submitted to the program pursuant to s. 961.37, Stats. (c) Information submitted to the program by a healthcare professional.
(d) Information from the analytics platform.
Section 8. CSB 4.02 (13) is amended to read:
Section 9. CSB 4.02 (14) is repealed.
Section 10. CSB 4.02 (15) (intro.) and (a) are consolidated, renumbered CSB 4.01 (15) and amended to read:
CSB 4.02 (15) “PDMP information data” means any of the following: The data the information compiled and stored analyzed by the board PDMP system from dispensing data submitted to it by dispensers.
Section 11. CSB 4.02 (15) (b) is repealed.
Section 12. CSB 4.02 (15b) and (15e) are created to read:
CSB 4.02 (15b) “PDMP system” means the web-based application, analytics platform, and all related hardware and software that facilitates the submission of dispensing data and the access to and disclosure of PDMP data, monitored prescription drug history reports, audit trails, and prescribing metrics reports.
(15e) “Personally identifiable information” means information that can be associated with a particular person through one or more identifiers or other information or circumstances.
Section 13. CSB 4.02 (15g), (15r), (16), (17) and (18) are amended to read:
CSB 4.02 (15g) “Pharmacist” has the meaning given in s. 961.385 (1) (aL), Stats. For the purposes of this program, the board recognizes a pharmacist licensed by another state that engages in the practice of pharmacy within the contiguous borders of this state or who practices at a pharmacy licensed under s. 450.065, Stats. as a person authorized to engage in the practice of pharmacy. (15r) “Pharmacist delegate” means an agent of a pharmacist to whom the pharmacist has delegated the task of accessing PDMP information monitored prescription drug history reports.
(16) “Pharmacy” means any place of practice licensed by has the board under ss. 450.06 or 450.065 meaning given in s. 961.385 (1) (an), Stats., including a pharmacy that chooses to solely dispense to animal patients. (17) “Practitioner” has the meaning given in s. 961.385 (1) (ar), Stats. For the purposes of this program, the board recognizes a practitioner licensed by another state that engages in the practice of their credentialed profession within the contiguous borders of this state as a person authorized to prescribe and administer drugs. (18) “Practitioner delegate” means an agent or employee of a practitioner to whom the practitioner has delegated the task of accessing PDMP information monitored prescription drug history reports.
Section 14. CSB 4.02 (18m) and (21m) are created to read:
CSB 4.02 (18m) “Prescribing metrics report” means all of the following information about a practitioner compiled by the PDMP system and disclosed as authorized in s. CSB 4.09: (a) PDMP data.
(b) Audit trails.
(c) Reports submitted to the program pursuant to s. 961.37, Stats. about a patient to whom the practitioner has issued a prescription order. (d) Information from the analytics platform.
(21m) “Prosecutorial unit” has the meaning given in s. 978.001 (2), Stats. Section 15. CSB 4.03 (2) is repealed.
Section 16. CSB 4.04 (1) (b), (d) and (e) are repealed.
Section 17. CSB 4.04 (2) (b),(e) and (i) and (4) are amended to read:
